Timing of chronic obstructive pulmonary disease diagnosis in lung cancer prognosis: A clinical and genomic-based study

Jie Dai, Yanqi He, Kunlatida Maneenil, Han Liu, Ming Liu, Qian Guo, Amy C. Bennett, Shawn M. Stoddard, Jason A. Wampfler, Gening Jiang, Ping Yang

Research output: Contribution to journalArticlepeer-review

Abstract

Background: A two-phase study (clinical and genomic-based) was conducted to evaluate the effect of timing of chronic obstructive pulmonary disease (COPD) diagnosis on lung cancer outcomes. Methods: The prognostic influence of COPD was investigated in a clinical cohort of 1,986 patients who received surgery for stage I lung cancer; 823 (41.4%) of them also had COPD, including 549 (27.6%) incidental COPD (diagnosed within 6-months of lung cancer diagnosis) and 274 (13.8%) prior COPD (>6 months before lung cancer diagnosis). The genomic variations were analyzed from another cohort of 1,549 patients for association with 384 lung cancer-related single nucleotide polymorphisms (SNPs). Results: Older age (≥70 years), smokers, and respiratory symptoms were independent predictors of incidental COPD in lung cancer (all P<0.05). Similar to prior COPD, incidental COPD increased postoperative complications and worsened quality-of-life related to dyspnea (both P<0.05). Multivariate Cox regression analysis showed lung cancer survival decreased significantly in incidental COPD (HR, 1.30; 95% CI, 1.02-1.66), but not in prior COPD (HR, 1.15; 95% CI, 0.87-1.52). Among prior COPD, median survival showed a trend for being better in those with fewer exacerbations (0-1 vs. ≥2 exacerbation/year; 6.1 vs. 4.1 years; P=0.10). The SNP-based analysis identified ADCY2:rs52827085 was significantly associated with risk of incidental COPD (OR, 1.76; 95% CI, 1.30-2.38) and NRXN1:rs1356888 associated with prior COPD complicated with lung cancer (OR, 1.73; 95% CI, 1.29-2.33). Conclusions: Different long-term survival and genomic variants were observed between lung cancer patients with incidental and with prior COPD, suggesting timing of COPD diagnosis should be considered in lung cancer clinical management and mechanistic research.

Original languageEnglish (US)
Pages (from-to)1209-1220
Number of pages12
JournalTranslational Lung Cancer Research
Volume10
Issue number3
DOIs
StatePublished - Mar 2021

Keywords

  • Chronic obstructive pulmonary disease (COPD)
  • Diagnosis
  • Lung cancer
  • Single nucleotide polymorphism (SNP)
  • Survival

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Timing of chronic obstructive pulmonary disease diagnosis in lung cancer prognosis: A clinical and genomic-based study'. Together they form a unique fingerprint.

Cite this